Back to Top

Oncology Research (OR)

Publisher :

Tech Science Press

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • clinical cancer research
  • clinical immunology
  • gene therapy
  • +4

e-ISSN :

1555-3906

Issue Frequency :

Monthly

Impact Factor :

4.1

p-ISSN :

0965-0407

Est. Year :

1993

Mobile :

17022592499

DOI :

YES

Country :

United States

Language :

English

APC :

YES

Impact Factor Assignee :

Google Scholar

Email :

oncologyresearch@techscience.com

Journal Descriptions

Oncology Research is committed to publishing high-quality, innovative research that is focused on the entire range of basic, translational, and clinical cancer research, with a particular interest in cancer therapeutics, providing a new platform for the understanding, prevention, diagnosis, and treatment of cancer. Oncology Research is committed to publishing high-quality, innovative research that is focused on the entire range of basic, translational, and clinical cancer research, with a particular interest in cancer therapeutics. Specific areas of interest include but are not limited to: identification of potential targets for cancers and the exploration of novel molecular mechanisms of tumorigenesis and metastasis; development of novel small molecules and targeted therapies;mechanisms of drug sensitivity; mechanisms of cellular drug resistance; biomarkers of response and/or resistance; novel experimental model systems and technologies relating to cancer therapeutics; pharmacogenetics and pharmacogenomics; personalized medicine; cancer stem cell; immunotherapy and clinical immunology; gene therapy; and radiobiology and novel approaches to radiation therapy either alone or in combination with chemotherapy. For studies that investigate the role of non-coding RNAs as regulators of cellular gene expression, it will be important for more in-depth mechanistic studies to be conducted that confirm their biological activity and their potential effect as mediators of chemosensitivity.


Oncology Research (OR) is :

International, Peer-Reviewed, Open Access, Refereed, clinical cancer research, clinical immunology, gene therapy, radiobiology, pharmacogenetics, pharmacogenomics, cancer stem cell , Online or Print, Monthly Journal

UGC Approved, ISSN Approved: P-ISSN - 0965-0407, E-ISSN - 1555-3906, Established in - 1993, Impact Factor - 4.1

Provide Crossref DOI

Indexed in Scopus, WoS, PubMed

Not indexed in DOAJ, UGC CARE

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile